Literature DB >> 14505124

Antimicrobial peptides in innate immunity of the human intestine.

Jan-Michel Otte1, Karlheinz Kiehne, Karl-Heinz Herzig.   

Abstract

The intestinal mucosa has to withstand exposure to a variety of substances, challenges in pH, temperature, and osmolarity; and, finally, bacterial products which might induce local and systemic inflammatory responses. The mucosal integrity is conserved by a defense system which consisting of constitutive and inducible mechanisms. These include the physical barrier function; the secretion of factors into the lumen, such as mucins and antibacterial substances; the mucosal immune system; and, finally, the ability of the mucosa to reconstitute once damage has occurred. The homeostasis and integrity of the gastrointestinal mucosa ultimately depends upon the balance between defensive and aggressive factors. While the physical barrier function was formerly believed to play the major role in mucosal protection against luminal bacteria, the recent discovery of Toll-like receptors and antimicrobial peptides in the intestinal epithelium has modified the concept of intestinal defense towards a more active character, which will be discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505124     DOI: 10.1007/s00535-003-1136-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  16 in total

Review 1.  Intestinal epithelial defense systems protect against bacterial threats.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Curr Gastroenterol Rep       Date:  2004-10

2.  Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.

Authors:  Edith Porter; Huixia Yang; Sujata Yavagal; Gloria C Preza; Omar Murillo; Heriberto Lima; Sheila Greene; Laily Mahoozi; Marcia Klein-Patel; Gill Diamond; Sunita Gulati; Tomas Ganz; Peter A Rice; Alison J Quayle
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Significant growth inhibition of orthotopic pancreatic ductal adenocarcinoma by CpG oligonucleotides in immunodeficient mice.

Authors:  J Tepel; O Dagvadorj; M Kapischke; B Sipos; A Leins; B Kremer; H Kalthoff
Journal:  Int J Colorectal Dis       Date:  2005-08-16       Impact factor: 2.571

4.  The role of intestinal epithelial barrier function in the development of NEC.

Authors:  Melissa D Halpern; Patricia W Denning
Journal:  Tissue Barriers       Date:  2015-01-22

5.  Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease.

Authors:  Sean W Mateer; Jocelle Cardona; Ellen Marks; Bridie J Goggin; Susan Hua; Simon Keely
Journal:  J Vis Exp       Date:  2016-02-09       Impact factor: 1.355

Review 6.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

7.  Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli.

Authors:  Karlheinz Kiehne; Gabriele Brunke; Franziska Wegner; Tomas Banasiewicz; Ulrich R Folsch; Karl-Heinz Herzig
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 8.  Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis.

Authors:  Claudia N Emami; Mikael Petrosyan; Stefano Giuliani; Monica Williams; Catherine Hunter; Nemani V Prasadarao; Henri R Ford
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

Review 9.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

10.  Food allergy in irritable bowel syndrome: new facts and old fallacies.

Authors:  E Isolauri; S Rautava; M Kalliomäki
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.